Browse
Explore conditions, clinical trials, and the organisations running them.
Up to: Endocrine gland neoplasm
Neuroendocrine neoplasm
Endocrine tumors, also referred to as neuroendocrine tumors (NETs), are defined by a common phenotype which is characterized by the expression of general markers (neuron specific enolase, chromogranin, synaptophysin) and hormone secretion products. These tumors may be localized in any part of the body and are generally discovered in non-specific situations, i.e. not immediately suggestive of NETs (tests for inherited predisposition to tumors or for a clinical syndrome caused by abnormal hormone secretion).
-
Neuroendocrine carcinoma 106 trials · 744 incl. sub-types Sub-types →
-
Lung neuroendocrine neoplasm 21 trials · 540 incl. sub-types Sub-types →
-
Digestive system neuroendocrine neoplasm 52 trials · 167 incl. sub-types Sub-types →
-
Paraganglioma 53 trials · 57 incl. sub-types Sub-types →
-
Carcinoid tumor 33 trials · 47 incl. sub-types Sub-types →
-
Prostate neuroendocrine neoplasm 20 trials · 25 incl. sub-types Sub-types →
-
Thymic neuroendocrine tumor 3 trials · 6 incl. sub-types Sub-types →
-
Bronchial endocrine tumor 4 trials
-
Ovarian neuroendocrine neoplasm 0 trials · 2 incl. sub-types Sub-types →